Pegylated recombinant human erythropoietin

pegylated recombinant human erythropoietin · Xiamen Amoytop Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegylated recombinant human erythropoietin, covering 2015-08-31 to 2015-08-31. Get the full timeline:

Most recent: Clinical Trial Update: PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual [Phase 1]